Lung uptake of radiolabeled skeletal agents has been
reported in a wide variety of disorders. Common underlying
metabolic or pathologic causes have been described.
But there has not been any report of pulmonary uptake of
MDP in patients with WMG, This observation is important,
because prompt recognition and appropriate treatment
may prevent increasing morbidity from pulmonary
dysfunctionLung uptake of radiolabeled skeletal agents has been
reported in a wide variety of disorders. Common underlying
metabolic or pathologic causes have been described.
But there has not been any report of pulmonary uptake of
MDP in patients with WMG, This observation is important,
because prompt recognition and appropriate treatment
may prevent increasing morbidity from pulmonary
dysfunction